These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21039884)

  • 1. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
    Karjalainen PP; Ylitalo A; Airaksinen JK; Nammas W
    J Interv Cardiol; 2011 Feb; 24(1):1-8. PubMed ID: 21039884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis.
    Limacher A; Räber L; Laube E; Lauterburg A; Lötscher S; Hess N; Moschovitis A; Baldinger SH; Wenaweser P; Meier B; Hess OM; Jüni P
    EuroIntervention; 2012 Jan; 7(9):1043-50. PubMed ID: 21959221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
    Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I
    J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.
    Karjalainen PP; Annala AP; Ylitalo A; Vahlberg T; Airaksinen KE
    Int J Cardiol; 2010 Sep; 144(1):42-6. PubMed ID: 19403187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
    Ong AT; Serruys PW; Aoki J; Hoye A; van Mieghem CA; Rodriguez-Granillo GA; Valgimigli M; Sonnenschein K; Regar E; van der Ent M; de Jaegere PP; McFadden EP; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT
    J Am Coll Cardiol; 2005 Apr; 45(7):1135-41. PubMed ID: 15808774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
    Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW;
    J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting.
    Karjalainen PP; Biancari F; Ylitalo A; Raeber L; Billinger M; Hess O; Airaksinen KE
    J Invasive Cardiol; 2010 Jul; 22(7):322-6. PubMed ID: 20603504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
    Jim MH; Ho HH; Ko RL; Siu CW; Yiu KH; Lau CP; Chow WH
    J Interv Cardiol; 2010 Feb; 23(1):40-5. PubMed ID: 20465719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort.
    Beijk MA; Claessen BE; Koch KT; Henriques JP; Baan J; Vis MM; Meesterman M; Tijssen JG; Piek JJ; de Winter RJ
    Int J Cardiol; 2010 Dec; 145(3):608-9. PubMed ID: 20850881
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of patients with coronary artery disease with biodegradable polymer based paclitaxel-eluting Infinnium coronary stent system: results of 1-year clinical follow-up a single center experience.
    Vedat A; Selcuk G; Refik E; Onur E; Murat C; Burak CA; Murat G; Cemsid D
    Indian Heart J; 2009; 61(3):254-7. PubMed ID: 20503830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
    Syed AI; Ben-Dor I; Collins SD; Gonzalez MA; Gaglia MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2010 Feb; 23(1):33-9. PubMed ID: 20465718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.
    Karjalainen PP; Ylitalo A; Airaksinen JK
    J Invasive Cardiol; 2006 Oct; 18(10):462-8. PubMed ID: 17042102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
    Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side balloon stenting of the left main bifurcation: a three-year angiographic follow-up.
    Latif F; Heldman AW; Hennebry TA
    J Interv Cardiol; 2009 Dec; 22(6):547-9. PubMed ID: 19735474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry.
    Balducelli M; Ortolani P; Marzaroli P; Piovaccari G; Menozzi A; Manari A; Sangiorgio P; Tarantino F; Rossi R; Maresta A; Tondi S; Passerini F; Guastaroba P; Grilli R; Marzocchi A
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):327-34. PubMed ID: 19937776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.